← Back to Search

ADAMM- RSM Device for Cystic Fibrosis

N/A
Waitlist Available
Led By Giovanni Ferrara, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month duration per participant
Awards & highlights

Study Summary

This trial will test a new device that monitors heart rate, breathing rate, temperature, cough, and activity to see if it can predict worsening or increasing severity of lung conditions.

Eligible Conditions
  • Cystic Fibrosis
  • Tuberculosis
  • Idiopathic Pulmonary Fibrosis
  • Lung Transplant
  • Bronchiectasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month duration per participant
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month duration per participant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of time wearing device (days)
Secondary outcome measures
Prediction of respiratory exacerbations- Number of emergency room visits
Prediction of respiratory exacerbations- Number of hospital admissions

Trial Design

1Treatment groups
Experimental Treatment
Group I: DeviceExperimental Treatment1 Intervention
All participants will wear the device to assist in determining the feasibility of wearing the device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADAMM- RSM Device
2021
N/A
~10

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,770 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
213 Patients Enrolled for Cystic Fibrosis
Giovanni Ferrara, MDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any openings available for the current clinical experiment?

"According to the information accessible through clinicaltrials.gov, this trial is open for recruitment of participants. It was initially posted on July 1st 2021 and recently updated on April 1st 2022."

Answered by AI

How many individuals have been recruited for participation in this investigation?

"The data available on clinicaltrials.gov affirms that this experiment is ongoing and looking to enrol participants. This research project was launched on July 1st 2021, with the most recent edit taking place April 1st 2022; there are currently 40 openings at a single medical centre."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
2021. "Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04857814.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top